← k3vl4r
Log inGet started →

CLDX (Celldex Therapeutics Inc) Price Forecast

AI-generated price forecast for Celldex Therapeutics Inc (CLDX) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

As of August 2026: K3vl4r's AI model currently reads CLDX as 2/2 bearish · strong across its horizons (0 of 2 timeframes pointing up), with a last price of 39.05. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

39.05

AI outlook

2/2 bearish · STRONG

Timeframes up

0 / 2

Share𝕏 Post✈ Telegram

CLDX forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour~8 weeks out———
Daily~5 months out▼ Down-35.12%0%
Weekly~1.9 years out▼ Down-8.82%—

Latest CLDX news

From the market-news feed the forecasts are read against.

  • Wells Fargo Maintains Overweight on Celldex Therapeutics, Raises Price Target to $72 · Benzinga · Jul 29
  • Celldex: 'Strong Buy' Barzolvolimab Carries To Q4 2026 CSU Data Readouts · SeekingAlpha · Jul 26
  • Wells Fargo Maintains Overweight on Celldex Therapeutics, Lowers Price Target to $48 · Benzinga · Jul 22
  • Morgan Stanley Maintains Overweight on Celldex Therapeutics, Lowers Price Target to $40 · Benzinga · Jul 22
  • Celldex Therapeutics, Inc. (CLDX) Discusses Phase II Barzolvolimab Results in Prurigo Nodularis and Trial Discontinuation - Slideshow · SeekingAlpha · Jul 22

🔒

See the full CLDX forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

CLDX forecast — frequently asked

Will CLDX go up?

K3vl4r's AI model currently reads CLDX as 2/2 bearish · STRONG — 0 of 2 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the CLDX price prediction for 2026?

K3vl4r's model projects CLDX toward $38.75 over the next ~5 months, a -0.4% move from $38.89. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could CLDX reach?

Over its longest horizon (~~1.9 years), the model's projected target for CLDX is $39.02 (-0.1% vs $39.05). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

PDSBAVTXAEMDZURAABEOMBRXMGRXALTNXLALGNAGENVNRXAUPHSNDA

Will CLDX reach…?

Will CLDX reach $50.00?Will CLDX reach $100.00?Will CLDX reach $200.00?Will CLDX reach $250.00?

Or see the full CLDX price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare CLDX

CLDX vs PDSBCLDX vs AVTXCLDX vs AEMDCLDX vs ZURACLDX vs ABEOCLDX vs MBRX

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

k3vl4rTop PicksTrack recordChart indicatorsToday's outlookBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch live forecasting on Twitch. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.